Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshiharu Maeda

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 23, 2008
[Two cases of stomach primary diffuse large B cell lymphoma remitted by Helicobacter pylori eradication therapy]Shingo Miyamoto, Rumiko Okamoto, Yoshiharu Maeda, et al.
Clinical Nephrology|June 3, 2014
Proteinuria is a simple sign of systemic inflammation that leads to a poor prognosis in individuals affected with non-Hodgkin lymphomaMasaki Hara, Minoru Ando, Yoshiharu Maeda, et al.
Clinical Lung Cancer|December 4, 2014
Response to cytotoxic chemotherapy in patients previously treated with palliative-intent chemotherapy for advanced thymic carcinomaYusuke Okuma, Yukio Hosomi, Satoshi Takahashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 17, 2006
[Clinicopathological characteristics of gastric cancer in elderly patients]Nantetsu Boku, Rumiko Okamoto, Kouji Kandabashi, et al.
Lung Cancer (Amsterdam, Netherlands)|March 21, 2014
The potency of curative-intent treatment for advanced thymic carcinomaYusuke Okuma, Hirotoshi Horio, Yukio Hosomi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 11, 2006
[The present state and future of home care for gastric cancer patients]Yoshiharu Maeda, Eisaku Sasaki, Michio Mikoshiba, et al.
Hematological Oncology|May 31, 2016
Beta-2 microglobulin as a significant prognostic factor and a new risk model for patients with diffuse large B-cell lymphomaYusuke Kanemasa, Tatsu Shimoyama, Yuki Sasaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 22, 2009
[A case of colon cancer with reversible posterior leukoencephalopathy syndrome following 5-FU and oxaliplatin (FOLFOX regime)]Yasunobu Nagata, Yasushi Omuro, Tatsu Shimoyama, et al.
Lung Cancer (Amsterdam, Netherlands)|January 15, 2013
Clinical outcomes with chemotherapy for advanced thymic carcinomaYusuke Okuma, Yukio Hosomi, Yusuke Takagi, et al.
Annals of Hematology|July 3, 2016
Central nervous system relapse in patients with diffuse large B cell lymphoma: analysis of the risk factors and proposal of a new prognostic modelYusuke Kanemasa, Tatsu Shimoyama, Yuki Sasaki, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 23, 2008
[Two cases of stomach primary diffuse large B cell lymphoma remitted by Helicobacter pylori eradication therapy]Shingo Miyamoto, Rumiko Okamoto, Yoshiharu Maeda, et al.
Clinical Nephrology|June 3, 2014
Proteinuria is a simple sign of systemic inflammation that leads to a poor prognosis in individuals affected with non-Hodgkin lymphomaMasaki Hara, Minoru Ando, Yoshiharu Maeda, et al.
Clinical Lung Cancer|December 4, 2014
Response to cytotoxic chemotherapy in patients previously treated with palliative-intent chemotherapy for advanced thymic carcinomaYusuke Okuma, Yukio Hosomi, Satoshi Takahashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 17, 2006
[Clinicopathological characteristics of gastric cancer in elderly patients]Nantetsu Boku, Rumiko Okamoto, Kouji Kandabashi, et al.
Lung Cancer (Amsterdam, Netherlands)|March 21, 2014
The potency of curative-intent treatment for advanced thymic carcinomaYusuke Okuma, Hirotoshi Horio, Yukio Hosomi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 11, 2006
[The present state and future of home care for gastric cancer patients]Yoshiharu Maeda, Eisaku Sasaki, Michio Mikoshiba, et al.
Hematological Oncology|May 31, 2016
Beta-2 microglobulin as a significant prognostic factor and a new risk model for patients with diffuse large B-cell lymphomaYusuke Kanemasa, Tatsu Shimoyama, Yuki Sasaki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 22, 2009
[A case of colon cancer with reversible posterior leukoencephalopathy syndrome following 5-FU and oxaliplatin (FOLFOX regime)]Yasunobu Nagata, Yasushi Omuro, Tatsu Shimoyama, et al.
Lung Cancer (Amsterdam, Netherlands)|January 15, 2013
Clinical outcomes with chemotherapy for advanced thymic carcinomaYusuke Okuma, Yukio Hosomi, Yusuke Takagi, et al.
Annals of Hematology|July 3, 2016
Central nervous system relapse in patients with diffuse large B cell lymphoma: analysis of the risk factors and proposal of a new prognostic modelYusuke Kanemasa, Tatsu Shimoyama, Yuki Sasaki, et al.
Pageof 4